Am J Perinatol 2022; 39(01): 061-066
DOI: 10.1055/s-0040-1714390
Original Article

Sequential Compression Device Adherence is Low in Hospitalized Antepartum Patients

Kelly S. Yamasato
1   Department of Obstetrics, Gynecology, and Women's Health, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii
,
Nicole B. Kurata
1   Department of Obstetrics, Gynecology, and Women's Health, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii
,
Sara C. Harris
1   Department of Obstetrics, Gynecology, and Women's Health, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii
,
Marguerite L. Bartholomew
1   Department of Obstetrics, Gynecology, and Women's Health, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii
› Author Affiliations

Abstract

Objective This study was aimed to describe sequential compression device (SCD) adherence and its associations with SCD education in hospitalized antepartum women.

Study Design This study included antepartum, nonlaboring women admitted from 2016 to 2018, 1 year before and after an SCD education intervention. SCD use was assessed through the Kendall SCD 700 series compliance meter, which tracks the time the SCD machine takes within the monitoring interval. Recruitment occurred after 60 to 80 hours of monitoring, at which time a patient survey was completed. SCD use was the percentage of time the machine was on during monitoring. Mann–Whitney U and Chi-square tests were used to compare associations between SCD use, education, and pharmacologic prophylaxis.

Results Among 125 recruited women, 123 provided adherence data, 69 before and 54 after the education. Median SCD use was 17.3% before and 20.7% after (p = 0.71). Pharmacologic prophylaxis use was similar between the two periods and was not associated with SCD use. Among 121 surveys, the most common reason as to why SCDs were not worn was prevention of walking (52/121 [43.0%]).

Conclusion Using a novel monitoring technique, we found low-SCD use among antepartum inpatients, which was neither affected by education nor concurrent pharmacologic prophylaxis. Improving mobility with SCDs may improve use in this population.

Key Points

  • SCD use was low in this cohort of hospitalized antepartum patients.

  • A patient/nursing education intervention was not associated with SCD adherence.

  • Concurrent pharmacologic VTE prophylaxis was not associated with SCD adherence.



Publication History

Received: 15 May 2020

Accepted: 16 June 2020

Article published online:
23 July 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton III LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005; 143 (10) 697-706
  • 2 James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194 (05) 1311-1315
  • 3 Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999; 54 (04) 265-271
  • 4 Ghaji N, Boulet SL, Tepper N, Hooper WC. Trends in venous thromboembolism among pregnancy-related hospitalizations, United States, 1994-2009. Am J Obstet Gynecol 2013; 209 (05) 433.e1-433.e8
  • 5 Abdul Sultan A, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England. BMJ 2013; 347: f6099
  • 6 D'Alton ME, Friedman AM, Smiley RM. et al. National partnership for maternal safety: consensus bundle on venous thromboembolism. Obstet Gynecol 2016; 128 (04) 688-698
  • 7 Rosenbloom JI, Macones GA. Future research directions for prevention and treatment of obstetric venous thromboembolism. Semin Perinatol 2019; 43 (04) 213-217
  • 8 Sibai BM, Rouse DJ. Pharmacologic thromboprophylaxis in obstetrics: broader use demands better data. Obstet Gynecol 2016; 128 (04) 681-684
  • 9 Comerota AJ, Chouhan V, Harada RN. et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997; 226 (03) 306-313 , discussion 313–314
  • 10 Jacobs DG, Piotrowski JJ, Hoppensteadt DA, Salvator AE, Fareed J. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results. J Trauma 1996; 40 (05) 710-716 , discussion 716–717
  • 11 Bockheim HM, McAllen KJ, Baker R, Barletta JF. Mechanical prophylaxis to prevent venous thromboembolism in surgical patients: a prospective trial evaluating compliance. J Crit Care 2009; 24 (02) 192-196
  • 12 Ritsema DF, Watson JM, Stiteler AP, Nguyen MM. Sequential compression devices in postoperative urologic patients: an observational trial and survey study on the influence of patient and hospital factors on compliance. BMC Urol 2013; 13: 20
  • 13 Brady MA, Carroll AW, Cheang KI, Straight C, Chelmow D. Sequential compression device compliance in postoperative obstetrics and gynecology patients. Obstet Gynecol 2015; 125 (01) 19-25
  • 14 Gray G, Ash AK. A survey of pregnant women on the use of graduated elastic compression stockings on the antenatal ward. J Obstet Gynaecol 2006; 26 (05) 424-428
  • 15 Stewart D, Zalamea N, Waxman K, Schuster R, Bozuk M. A prospective study of nurse and patient education on compliance with sequential compression devices. Am Surg 2006; 72 (10) 921-923